Literature DB >> 29570780

Effects of ischemic post-conditioning on neuronal VEGF regulation and microglial polarization in a rat model of focal cerebral ischemia.

Elga Esposito1, Kazuhide Hayakawa1, Bum Ju Ahn1,2, Su Jing Chan1,3, Changhong Xing1, Anna C Liang1, Kyu-Won Kim2, Ken Arai1, Eng H Lo1.   

Abstract

Ischemic postconditioning is increasingly being investigated as a therapeutic approach for cerebral ischemia. However, the majority of studies are focused on the acute protection of neurons per se. Whether and how postconditioning affects multiple cells in the recovering neurovascular unit remains to be fully elucidated. Here, we asked whether postconditioning may modulate help-me signaling between injured neurons and reactive microglia. Rats were subjected to 100 min of focal cerebral ischemia, then randomized into a control versus postconditioning group. After 3 days of reperfusion, infarct volumes were significantly reduced in animals treated with postconditioning, along with better neurologic outcomes. Immunostaining revealed that ischemic postconditioning increased expression of vascular endothelial growth factor (VEGF) in neurons within peri-infarct regions. Correspondingly, we confirmed that VEGFR2 was expressed on Iba1-positive microglia/macrophages, and confocal microscopy showed that in postconditioned rats, these cells were polarized to a ramified morphology with higher expression of M2-like markers. Treating rats with a VEGF receptor 2 kinase inhibitor negated these effects of postconditioning on microglia/macrophage polarization. In vitro, postconditoning after oxygen-glucose deprivation up-regulated VEGF release in primary neuron cultures, and adding VEGF to microglial cultures partly shifted their M2-like markers. Altogether, our findings support the idea that after postconditioning, injured neurons may release VEGF as a 'help-me' signal that promotes microglia/macrophage polarization into potentially beneficial phenotypes.
© 2018 International Society for Neurochemistry.

Entities:  

Keywords:  microglia; neuroprotection; neurovascular unit; postconditioning; stroke

Mesh:

Substances:

Year:  2018        PMID: 29570780      PMCID: PMC6105375          DOI: 10.1111/jnc.14337

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  40 in total

1.  ASIC1a contributes to neuroprotection elicited by ischemic preconditioning and postconditioning.

Authors:  Giuseppe Pignataro; Ornella Cuomo; Elga Esposito; Rossana Sirabella; Gianfranco Di Renzo; Lucio Annunziato
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2010-09-10

2.  Oxygen-glucose deprivation and interleukin-1α trigger the release of perlecan LG3 by cells of neurovascular unit.

Authors:  Maxim G Saini; Emmanuel Pinteaux; Boyeon Lee; Gregory J Bix
Journal:  J Neurochem       Date:  2011-10-11       Impact factor: 5.372

3.  Voluntary exercise induces a BDNF-mediated mechanism that promotes neuroplasticity.

Authors:  Fernando Gómez-Pinilla; Zhe Ying; Roland R Roy; Raffaella Molteni; V Reggie Edgerton
Journal:  J Neurophysiol       Date:  2002-11       Impact factor: 2.714

4.  Inhibition of brain ischemia-caused notch activation in microglia may contribute to isoflurane postconditioning-induced neuroprotection in male rats.

Authors:  Jinbo Yin; Hong Li; Chenzhuo Feng; Zhiyi Zuo
Journal:  CNS Neurol Disord Drug Targets       Date:  2014       Impact factor: 4.388

5.  In vivo and in vitro characterization of a novel neuroprotective strategy for stroke: ischemic postconditioning.

Authors:  Giuseppe Pignataro; Robert Meller; Koichi Inoue; Andrea N Ordonez; Michelle D Ashley; Zhigang Xiong; Rosaria Gala; Roger P Simon
Journal:  J Cereb Blood Flow Metab       Date:  2007-09-19       Impact factor: 6.200

Review 6.  Role and therapeutic potential of VEGF in the nervous system.

Authors:  Carmen Ruiz de Almodovar; Diether Lambrechts; Massimiliano Mazzone; Peter Carmeliet
Journal:  Physiol Rev       Date:  2009-04       Impact factor: 37.312

7.  Reversible middle cerebral artery occlusion without craniectomy in rats.

Authors:  E Z Longa; P R Weinstein; S Carlson; R Cummins
Journal:  Stroke       Date:  1989-01       Impact factor: 7.914

8.  Effects of ischemic preconditioning on VEGF and pFlk-1 immunoreactivities in the gerbil ischemic hippocampus after transient cerebral ischemia.

Authors:  Yoo Seok Park; Jun Hwi Cho; In Hye Kim; Geum-Sil Cho; Jeong-Hwi Cho; Joon Ha Park; Ji Hyeon Ahn; Bai Hui Chen; Bich-Na Shin; Myoung Cheol Shin; Hyun-Jin Tae; Young Shin Cho; Yun Lyul Lee; Young-Myeong Kim; Moo-Ho Won; Jae-Chul Lee
Journal:  J Neurol Sci       Date:  2014-10-02       Impact factor: 3.181

9.  The Akt signaling pathway contributes to postconditioning's protection against stroke; the protection is associated with the MAPK and PKC pathways.

Authors:  Xuwen Gao; Hanfeng Zhang; Tetsuya Takahashi; Jason Hsieh; Janette Liao; Gary K Steinberg; Heng Zhao
Journal:  J Neurochem       Date:  2008-01-07       Impact factor: 5.372

10.  Ischemic postconditioning prevents renal ischemia reperfusion injury through the induction of heat shock proteins in rats.

Authors:  Qiongmei Guo; Xuefang Du; Yanli Zhao; Dong Zhang; Lihui Yue; Zhenxian Wang
Journal:  Mol Med Rep       Date:  2014-10-14       Impact factor: 2.952

View more
  17 in total

1.  Regulation of blood-brain barrier integrity by microglia in health and disease: A therapeutic opportunity.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  J Cereb Blood Flow Metab       Date:  2020-09-14       Impact factor: 6.200

2.  Microglial responses after phagocytosis: Escherichia coli bioparticles, but not cell debris or amyloid beta, induce matrix metalloproteinase-9 secretion in cultured rat primary microglial cells.

Authors:  Gen Hamanaka; Tomoya Kubo; Ryo Ohtomo; Hajime Takase; Estefania Reyes-Bricio; Shuntaro Oribe; Noriko Osumi; Josephine Lok; Eng H Lo; Ken Arai
Journal:  Glia       Date:  2020-02-14       Impact factor: 7.452

3.  Protective limb remote ischemic post-conditioning against high-intraocular-pressure-induced retinal injury in mice.

Authors:  Qi-Jiang Zhu; Lei Zhang; Shuang-Yu Lyu; Zhan-Jun Cui; En-She Jiang; Jun Wang
Journal:  Int J Ophthalmol       Date:  2022-04-18       Impact factor: 1.779

4.  Ischemic postconditioning for stroke treatment: current experimental advances and future directions.

Authors:  Hansen Chen; Jiangang Shen; Heng Zhao
Journal:  Cond Med       Date:  2020-05-05

Review 5.  Pivotal role of innate myeloid cells in cerebral post-ischemic sterile inflammation.

Authors:  Jun Tsuyama; Akari Nakamura; Hiroaki Ooboshi; Akihiko Yoshimura; Takashi Shichita
Journal:  Semin Immunopathol       Date:  2018-09-11       Impact factor: 9.623

6.  Protective effects of leonurine against ischemic stroke in mice by activating nuclear factor erythroid 2-related factor 2 pathway.

Authors:  Yan-Zhao Xie; Xiang-Jian Zhang; Cong Zhang; Yang Yang; Jun-Na He; Yan-Xia Chen
Journal:  CNS Neurosci Ther       Date:  2019-05-13       Impact factor: 5.243

7.  Wnt canonical pathway activator TWS119 drives microglial anti-inflammatory activation and facilitates neurological recovery following experimental stroke.

Authors:  Degang Song; Xiangjian Zhang; Junmin Chen; Xiaoxia Liu; Jing Xue; Lan Zhang; Xifa Lan
Journal:  J Neuroinflammation       Date:  2019-12-06       Impact factor: 8.322

8.  Ischemic Postconditioning Mitigates Retinopathy in Tree Shrews with Diabetic Cerebral Ischemia.

Authors:  Ling Zhao; Qiwei Liao; Yueting Zhang; Shufen Tan; Shuqing Li; Tingyu Ke
Journal:  J Diabetes Res       Date:  2020-02-12       Impact factor: 4.011

9.  Astragaloside IV improves angiogenesis under hypoxic conditions by enhancing hypoxia‑inducible factor‑1α SUMOylation.

Authors:  Baoshen Wang; Chunyan Zhang; Dongmei Chu; Xiaofang Ma; Tian Yu; Xiaozhi Liu; Changqing Hu
Journal:  Mol Med Rep       Date:  2021-02-04       Impact factor: 2.952

Review 10.  Regenerative Potential of Carbon Monoxide in Adult Neural Circuits of the Central Nervous System.

Authors:  Eunyoung Jung; Seong-Ho Koh; Myeongjong Yoo; Yoon Kyung Choi
Journal:  Int J Mol Sci       Date:  2020-03-25       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.